Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Arcus Biosciences, Inc.
AstraZeneca
Regeneron Pharmaceuticals
Inhibrx Biosciences, Inc
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Prestige Biopharma Limited
Fundación GECP
Actuate Therapeutics Inc.